OM:ADDERA

Stock Analysis Report

Executive Summary

AdderaCare AB, through its subsidiaries, operates in the home care sector.

Snowflake

Fundamentals

Fair value with questionable track record.

Share Price & News

How has AdderaCare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.4%

ADDERA

5.5%

SE Medical Equipment

2.1%

SE Market


1 Year Return

-37.8%

ADDERA

34.0%

SE Medical Equipment

12.1%

SE Market

Return vs Industry: ADDERA underperformed the Swedish Medical Equipment industry which returned 34% over the past year.

Return vs Market: ADDERA underperformed the Swedish Market which returned 12.1% over the past year.


Shareholder returns

ADDERAIndustryMarket
7 Day3.4%5.5%2.1%
30 Day-4.5%1.3%1.6%
90 Day-3.5%1.6%3.7%
1 Year-37.8%-37.8%35.4%34.0%16.8%12.1%
3 Yearn/a54.9%36.6%32.2%12.4%
5 Yearn/a72.9%44.6%62.8%28.3%

Price Volatility Vs. Market

How volatile is AdderaCare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is AdderaCare undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ADDERA (SEK5.5) is trading below our estimate of fair value (SEK14.56)

Significantly Below Fair Value: ADDERA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ADDERA is poor value based on its PE Ratio (70.2x) compared to the Medical Equipment industry average (44x).

PE vs Market: ADDERA is poor value based on its PE Ratio (70.2x) compared to the Swedish market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ADDERA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ADDERA is good value based on its PB Ratio (0.9x) compared to the SE Medical Equipment industry average (4.4x).


Next Steps

Future Growth

How is AdderaCare forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

4.5%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ADDERA's forecast earnings growth is above the savings rate (0.4%).

Earnings vs Market: Insufficient data to determine if ADDERA's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ADDERA's revenue (4.5% per year) is forecast to grow faster than the Swedish market (4.5% per year).

High Growth Revenue: ADDERA's revenue (4.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ADDERA's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has AdderaCare performed over the past 5 years?

-40.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: ADDERA's earnings have declined by -40.2% per year over the past 5 years.

Accelerating Growth: ADDERA's earnings growth over the past year (23.6%) exceeds its 5-year average (-40.2% per year).

Earnings vs Industry: ADDERA earnings growth over the past year (23.6%) exceeded the Medical Equipment industry 17.3%.


Return on Equity

High ROE: ADDERA's Return on Equity (1.3%) is considered low.


Return on Assets

ROA vs Industry: ADDERA's Return on Assets is below or equal to the Medical Equipment industry average last year.


Return on Capital Employed

ROCE Improving: ADDERA's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is AdderaCare's financial position?


Financial Position Analysis

Short Term Liabilities: ADDERA's short term assets (SEK88.0M) do not cover its short term liabilities (SEK91.6M)

Long Term Liabilities: ADDERA's short term assets (88.0M) exceeds its long term liabilities (41.7M)


Debt to Equity History and Analysis

Debt Level: ADDERA's debt to equity ratio (43.5%) is considered high

Reducing Debt: Insufficient data to determine if ADDERA's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: ADDERA's debt is well covered by operating cash flow (27.6%).

Interest Coverage: ADDERA's interest payments on its debt are not well covered by EBIT (2.3x coverage).


Balance Sheet

Inventory Level: ADDERA has a high level of physical assets or inventory.

Debt Coverage by Assets: ADDERA's debt is covered by short term assets (assets are 1.980770x debt).


Next Steps

Dividend

What is AdderaCare's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.8%markettop25%4.6%industryaverage1.1%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate ADDERA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ADDERA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if ADDERA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ADDERA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ADDERA's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

What is the CEO of AdderaCare's salary, the management and board of directors tenure and is there insider trading?

3.8yrs

Average board tenure


CEO

Marianne Sernevi (52yo)

0.08yrs

Tenure

0

Ms. Marianne Sernevi has been Chief Executive Officer of AdderaCare AB since September 2019. Ms. Sernevi has been Chief Executive Officer of Skånska Energi AB since 2016. Ms. Sernevi served as the Chief Ex ...


Board Age and Tenure

3.8yrs

Average Tenure

60yo

Average Age

Experienced Board: ADDERA's board of directors are considered experienced (3.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Buykr92,96128 Mar 19
Michael Hermansson
EntityIndividual
Shares16,034
Max Pricekr5.86

Ownership Breakdown


Management Team

  • Marianne Sernevi (52yo)

    Chief Executive Officer

    • Tenure: 0.08yrs
  • Henrik Carlsson (53yo)

    Chief Financial Officer

    • Tenure: 0yrs

Board Members

  • Marianne Alexandersson (60yo)

    Director

    • Tenure: 3.8yrs
    • Compensation: kr50.00k
  • Hans Andersson (66yo)

    Director

    • Tenure: 0.4yrs
  • Per Nilsson (66yo)

    Chairman

    • Tenure: 3.8yrs
    • Compensation: kr90.00k
  • Leif Lindau (56yo)

    Director

    • Tenure: 3.8yrs
    • Compensation: kr50.00k
  • Rickard Benediktsson (51yo)

    Director

    • Tenure: 3.8yrs
    • Compensation: kr50.00k

Company Information

AdderaCare AB's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: AdderaCare AB
  • Ticker: ADDERA
  • Exchange: OM
  • Founded: 2013
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr101.767m
  • Shares outstanding: 18.50m
  • Website: https://www.adderacare.com

Location

  • AdderaCare AB
  • Hans Michelsensgatan 9
  • Malmö
  • Skåne County
  • 211 20
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ADDERAOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKDec 2016

Biography

AdderaCare AB, through its subsidiaries, operates in the home care sector. The company offers ramps for housing adaptations; stairs and lifts, and bathroom equipment for people with functional limitations; ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 21:52
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.